Use of pharmacological therapy localized in periodontics: Literature review
DOI:
https://doi.org/10.33448/rsd-v11i13.36053Keywords:
Periodontal disease; Drug therapy; Antimicrobial therapy.Abstract
When the microorganisms are eliminated before the pathological evolution occurs, the periodontal tissues return to their normality, however, impacts after treatment such as bone loss are still possible. In this sense, the control and maintenance of oral hygiene is a determining factor for therapeutic success, however, factors such as tobacco and stress are associated with failure. Even so, limitations such as access in furcation regions, reservoir of bacteria in the dentinal tubules, deep pockets and even concavities, can facilitate the recolonization of bacteria after mechanical treatment. In this perspective, the present study aims to gather and report the drugs used as local therapy in periodontics, as well as present their advantages and disadvantages, in order to understand the best pharmacotherapeutic applicability. In this way, it is understood that treatment with local drugs is an essential factor for success in periodontal treatment, since only mechanical control and the presence of factors such as tobacco and stress make the treatment inefficient. Furthermore, further studies are needed to better prove the therapeutic efficacy.
References
Angst, P. D. M., Gomes, S. C., & Oppermann, R. V. (2015). Do controle de placa ao controle do biofilme supragengival: o que aprendemos ao longo dos anos? Revista da Associacao Paulista de Cirurgioes Dentistas, 69(3), 252-259.
Braz, A. J. S., dos Santos Fagundes, D., & Espíndola, L. C. P. (2021). O uso da própolis como coadjuvante ao tratamento periodontal. Research, Society and Development, 10(17), e182101724341-e182101724341.
Caton, J. G., Armitage, G., Berglundh, T., Chapple, I. L., Jepsen, S., Kornman, K. S., & Tonetti, M. S. (2018). A new classification scheme for periodontal and peri‐implant diseases and conditions–Introduction and key changes from the 1999 classification. Journal of periodontology, 89, S1-S8.
Czerniuk, M. R., Bartoszewicz, Z., Filipiak, K. J., Dudzik-Niewiadomska, I., Pilecki, T., & Górska, R. (2017). Plasmatic NT-proBNP concentrations in patients with coexistent periodontal disease and congestive heart failure: pilot studies. Kardiologia Polska (Polish Heart Journal), 75(2), 135-142.
da Silva, A. F., da Silva, E. T. C., da Costa, S. R. R., Bezerra, P. L., Lourenço, A. H. A., & de Macedo Bernardino, Í. (2021). O uso do aloe vera como coadjuvante no tratamento periodontal. Research, Society and Development, 10(1), e7110111511-e7110111511.
Dentino, A., Lee, S., Mailhot, J., & Hefti, A. F. (2013). Principles of periodontology. Periodontology 2000, 61(1), 16-53.
Garg, S. (2015). Local drug delivery systems as an adjunct to cure periodontitis–The novel dental applicant. Pharm Methods, 6(1), 01-08.
How, K. Y., Song, K. P., & Chan, K. G. (2016). Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Frontiers in microbiology, 7, 53.
Javed, S., & Kohli, K. (2010). Local delivery of minocycline hydrochloride: a therapeutic paradigm in periodontal diseases. Current drug delivery, 7(5), 398-406.
Kapsar, K. E., Hovis, C. L., Bicudo da Silva, R. F., Buchholtz, E. K., Carlson, A. K., Dou, Y., & Liu, J. (2019). Telecoupling research: The first five years. Sustainability, 11(4), 1033.
Leszczyńska, A., Buczko, P., Buczko, W., & Pietruska, M. (2011). Periodontal pharmacotherapy–an updated review. Advances in medical sciences, 56(2), 123-131.
Marinho, R. R. B., Damasceno, J. T. B. N., & do Nascimento, R. S. V. (2022). Aspecto etiológico, imunológico e patogênico da doença periodontal Etiological, immunological and pathogenic aspects of periodontal disease. Brazilian Journal of Health Review, 5(3), 1094-10504.
Medaiah, S., Srinivas, M., Melath, A., Girish, S., Polepalle, T., & Dasari, A. B. (2014). Chlorhexidine chip in the treatment of chronic periodontitis–a clinical study. Journal of Clinical and Diagnostic Research: JCDR, 8(6), ZC22.
Pandit, N., Dahiya, R., Gupta, R., Bali, D., & Kathuria, A. (2013). Comparative evaluation of locally delivered minocycline and metronidazole in the treatment of periodontitis. Contemporary clinical dentistry, 4(1), 48.
Panhwar, M., Rajpar, S. P., Abrar, E., Alqutub, M., & Abduljabbar, T. (2021). Effectiveness of Chlorhexidine and Metronidazole Gels in the management of gingivitis. A clinical trial. Pakistan Journal of Medical Sciences, 37(5), 1425.
Prietto, N. R., Martins, T. M., dos Santos Santinoni, C., Pola, N. M., Ervolino, E., Bielemann, A. M., & Leite, F. R. M. (2020). Treatment of experimental periodontitis with chlorhexidine as adjuvant to scaling and root planing. Archives of oral biology, 110, 104600.
Seok, H., Kim, S. G., Kweon, H., Jo, Y. Y., Lee, K. G., Kang, T. Y., & Choi, D. J. (2014). Comparison of different concentrations of tetracycline-loaded silk fibroin membranes on the guided bone regeneration in the rat calvarial defect model. Tissue Engineering and Regenerative Medicine, 11(6), 476-482.
Slots, J. (2012). Low‐cost periodontal therapy. Periodontology 2000, 60(1), 110-137.
Soares, G. M. S., Figueiredo, L. C., Faveri, M., Cortelli, S. C., Duarte, P. M., & Feres, M. (2012). Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs. Journal of applied oral science, 20, 295-309.
Tonetti, M. S., Greenwell, H., & Kornman, K. S. (2018). Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. Journal of periodontology, 89, S159-S172.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Lauralice Tavares Silva; Dayanne Larissa Ferreira de Santana; Maria Eduarda Guimarães de Andrade Teixeira Nascimento; Rayza Dayane Silva de Mendonça; José Thomas Azevedo de Queiroz; Adriano Costa Ramos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
